Sandbox: ESC guidelines: Difference between revisions
No edit summary |
|||
(11 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} | |||
==Overview== | ==Overview== | ||
The '''Class''' designation is used to indicate whether a therapy is recommended or not and the certainty surrounding that recommendation. | The '''Class''' designation is used to indicate whether a therapy is recommended or not and the certainty surrounding that recommendation. | ||
===Class I: | ==Classes of Recommendation <ref name="pmid229224152">{{cite journal| author=Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC). European Association for Cardio-Thoracic Surgery (EACTS). Vahanian A, Alfieri O, Andreotti F, Antunes MJ et al.| title=Guidelines on the management of valvular heart disease (version 2012). | journal=Eur Heart J | year= 2012 | volume= 33 | issue= 19 | pages= 2451-96 | pmid=22922415 | doi=10.1093/eurheartj/ehs109 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22922415 }}</ref>== | ||
===Class I:=== | |||
Conditions for which there is evidence and/or general agreement that a given procedure or treatment is beneficial, useful, and effective. | Conditions for which there is evidence and/or general agreement that a given procedure or treatment is beneficial, useful, and effective. | ||
Line 11: | Line 13: | ||
Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment. | Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment. | ||
=====Class IIa: | =====Class IIa:===== | ||
Weight of evidence/opinion is in favor of usefulness/efficacy. | Weight of evidence/opinion is in favor of usefulness/efficacy. | ||
=====Class IIb: | =====Class IIb:===== | ||
Usefulness/efficacy is less well established by evidence/opinion. | Usefulness/efficacy is less well established by evidence/opinion. | ||
===Class III=== | ===Class III=== | ||
Conditions for which there is evidence and/or general agreement that a procedure/treatment is not useful/effective and in some cases may be harmful. | Conditions for which there is evidence and/or general agreement that a procedure/treatment is not useful/effective and in some cases may be harmful. | ||
==Level Of Evidence== | ==Level Of Evidence== | ||
Line 34: | Line 28: | ||
====Level of Evidence B:==== | ====Level of Evidence B:==== | ||
*Data derived from one or more randomized trials or meta-analysis of such studies. | |||
*Data derived from one or more non-randomized trials or meta-analysis of such studies. | |||
===Level of Evidence C:=== | |||
*Non randomized observational studies with limitations in design or execution or Metanalysis of such studies. | |||
*Consensus opinion of experts based on clinical experience. | |||
== | ==According to 2012, Guidelines on the management of valvular heart disease== | ||
: | [[File:Screen Shot 2016-12-20 at 3.21.29 pm.png]] | ||
[[File:Screen Shot 2016-12-20 at 3.23.05 pm.png]] | [[File:Screen Shot 2016-12-20 at 3.23.05 pm.png]] | ||
==References== | |||
{{Reflist|2}} | |||
{{WH}} {{WS}} |
Latest revision as of 21:05, 20 December 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The Class designation is used to indicate whether a therapy is recommended or not and the certainty surrounding that recommendation.
Classes of Recommendation [1]
Class I:
Conditions for which there is evidence and/or general agreement that a given procedure or treatment is beneficial, useful, and effective.
Class II:
Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment.
Class IIa:
Weight of evidence/opinion is in favor of usefulness/efficacy.
Class IIb:
Usefulness/efficacy is less well established by evidence/opinion.
Class III
Conditions for which there is evidence and/or general agreement that a procedure/treatment is not useful/effective and in some cases may be harmful.
Level Of Evidence
Level of Evidence A:
Data derived from multiple randomized clinical trials or meta-analyses of such studies.
Level of Evidence B:
- Data derived from one or more randomized trials or meta-analysis of such studies.
- Data derived from one or more non-randomized trials or meta-analysis of such studies.
Level of Evidence C:
- Non randomized observational studies with limitations in design or execution or Metanalysis of such studies.
- Consensus opinion of experts based on clinical experience.
According to 2012, Guidelines on the management of valvular heart disease
References
- ↑ Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC). European Association for Cardio-Thoracic Surgery (EACTS). Vahanian A, Alfieri O, Andreotti F, Antunes MJ; et al. (2012). "Guidelines on the management of valvular heart disease (version 2012)". Eur Heart J. 33 (19): 2451–96. doi:10.1093/eurheartj/ehs109. PMID 22922415.